The aim of this study is to contribute to a better understanding of malaria by P. vivax and to support and accelerate the development of new control tools, with a special focus in vaccines. This fact will promote the creation and development of a research line on P. vivax in CRESIB under the direction of Dr. Hernando A. del Portillo, one of the few specialists in molecular biology and vaccine development against this parasite. The number of CRESIB labs will be increased, with an enlargement and restoration of current facilities to meet the needs of the centre.
Malaria is an infectious disease which can be caused by four species of the Plasmodium parasite: P. falciparum, P. vivax, P. malariae and P. ovale. P. falciparum and P. vivax are the most prevalent, the first being more virulent and responsible of most of the severe morbidity and mortality. Nevertheless, during the last years, there has been a growing interest in malaria by P. vivax, which, as well as causing millions of malaria cases every year, it also generates a high social and economic cost for endemic countries. It is estimated that about 2,600 million people live in risk zones for P. vivax: central and south-America, Asia, Middle East and occidental Pacific. Clinical and pathogen presentation of P. vivax is not well understood. Despite the traditional belief that clinical malaria caused by this species of the parasite is mild, there are evidences suggesting that it can cause severe clinical patterns and even death of patients.
The paradox is that even though malaria by P. vivax has large global disease burden, this is a poorly studied disease, which has been long forgotten. Consequently, this new research programme has a large importance, and an estimated initial duration of 4 years.
This is the reason why CRESIB, through DR. Hernando A. del Portillo, specialist in molecular biology and vaccine development against Plasmodium vivax, gives plenty of importance to the development of new control tools for this type of malaria.
In the field of malaria by P. vivax, there has been until now a lack of initiatives to promote the global effort in the research on this disease. With the experience of the CRESIB group in malaria and of the Clínic Foundation for Biomedical Research (FCRB, Fundació Clínic per a la Recerca Biomèdica) in the management and coordination of projects of international research, an international consortium of research in P. vivax will be created and promoted. This consortium will be constituted by leading malaria research centres, and will be coordinated from Barcelona.
Research centres collaborating in this project, mostly placed in malaria endemic areas by Plasmodium vivax, are: Papua New Guinea Institute of Medical Research, located in Papua New Guinea; the International Centre for Genetic Engineering and Biotechnology, located in New Delhi (India), the Tropical Medicine Foundation of Amazonas, in Manaus (Brazil) and the International Vaccine Centre, located in Cali (Colombia).
CRESIB has a scientific programme including research on diseases causing an important part of the morbidity and mortality in low-income countries, specially malaria, acute respiratory infections, diarrhoeas, tuberculosis and AIDS. Furthermore, CRESIB sets its sights on promoting research related to other aspects of international health, such as emergent, reemergent and immunopreventable diseases, health, immigration and climate and health. Research conducted by CRESIB researchers is currently developed in the facilities located in the Campus of the Faculty of Medicine of the Universitat de Barcelona-Hospital Clínic.
Department of Communication and External Relations of the IDIBAPS - Hospital Clínic of BarcelonaFor further information, please contact us at +34 93 227 57 00
New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia
New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences